Long-read whole-genome sequencing for the genetic diagnosis of dystrophinopathies

Ann Clin Transl Neurol. 2020 Oct;7(10):2041-2046. doi: 10.1002/acn3.51201. Epub 2020 Sep 20.

Abstract

The precise genetic diagnosis of dystrophinopathies can be challenging, largely due to rare deep intronic variants and more complex structural variants (SVs). We report on the genetic characterization of a dystrophinopathy patient. He remained without a genetic diagnosis after routine genetic testing, dystrophin protein and mRNA analysis, and short- and long-read whole DMD gene sequencing. We finally identified a novel complex SV in DMD via long-read whole-genome sequencing. The variant consists of a large-scale (~1Mb) inversion/deletion-insertion rearrangement mediated by LINE-1s. Our study shows that long-read whole-genome sequencing can serve as a clinical diagnostic tool for genetically unsolved dystrophinopathies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dystrophin / genetics
  • Dystrophin / metabolism*
  • Genome, Human / immunology*
  • Humans
  • Male
  • Muscular Dystrophy, Duchenne / diagnosis
  • Mutation / drug effects*
  • RNA, Messenger / metabolism*
  • Whole Genome Sequencing / methods

Substances

  • Dystrophin
  • RNA, Messenger

Grants and funding

This work was funded by Beijing Municipal Science and Technology Commission grant Z191100006619034.